Description
Inclusion Criteria:
- * Subject is willing and able to read, understand, and sign the informed consent.
- * Healthy male or female aged 35 - 55 years.
- * Fitzpatrick skin type 1-6.
- * Subject is capable of reading, understanding, and following instructions of the procedure to be applied.
- * Subject is able and willing to comply with the treatment. Women in childbearing age who is willing to conduct a pregnancy test prior to each treatment.
Exclusion Criteria:
- * Pregnant, lactating, or plans to become pregnant during the study period or had given birth less than 6 months ago.
- * Concurrent participation in any other study.
- * Subject has a pacemaker or internal defibrillator, implanted neurostimulators or any other internal electric device or patient who had an implant in the past.
- * Subject has metal or other implants in the treatment area (Not including dental fillings, implants and crowns).
- * Subject has significant concurrent skin conditions affecting areas to be treated such as sores, bleeding, skin fragility, eczema or psoriasis.
- * Subject has burned, blistered, irritated, or sensitive skin due to excessive fresh tanning in areas to be treated or is unlikely to refrain from excessive tanning during the study.
- * Subject has used oral isotretinoin (Accutane® or Roaccutan®) within 6 months prior to study.
- * Subject has used topical retinoids in the past 1 month.
- * History of systemic cancer; premalignant skin lesion or skin concern treatment area.
- * Concurrent conditions such as epilepsy, autoimmune, pulmonary or cardiac disorders.
- * Poorly controlled endocrine disorders such as diabetes.
- * Impaired immune system due to immunosuppressive diseases such as HIV or AIDS, or use of immunosuppressive medications.
- * History of collagen disorders, keloid formation or abnormal wound healing.
- * Takes or has taken medications, herbal preparations, food supplements or vitamins that might cause fragile skin or impaired skin healing.
- * Subject has used oral steroids in the past 6 months.
- * Subject has used topical steroids in the past 3 months.
- * History of bleeding coagulopathies or use of anticoagulants.
- * Use of non-steroidal anti-inflammatory drugs (NSAIDS, e.g. ibuprofen containing agents) one week before and after each treatment session prior to treatment.
- * Subjects who cannot feel heat to give proper treatment feedback. (nerve damage, etc.)
- * Mental disorders that in the opinion of the Investigator would interfere with the ability to comply with the study requirements.
- * Subject has any other medical condition that in the opinion of the Investigator warrants exclusion from this study.
Ages Eligible for Study:
35 Years to 55 Years (ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Yes